Inhibition of OSCC derived ExomiRs and its therapeutic applications in oral cancer. Sekar D. Oral Oncol 2022;126:105747.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sekar D. Inhibition of OSCC derived ExomiRs and its therapeutic applications in oral cancer. Oral Oncol 2022;126:105747.
PMID: 35093698